$330,000–$370,000/yr
United States
Unlimited PTO
- Build the clinical development plan and first-in-human strategy from the ground up.
- Design the Phase 1 protocol: dose, endpoints, population, pharmacodynamic readouts, and design nuance across two therapeutic areas.
- Shape the translational and biomarker strategy to turn a preclinical mechanism into a credible human proof-of-mechanism readout.